Study, year | Total bleeding events LMWH (n/N) | Total bleeding events UFH (n/N) | RR (95% CI) | Comments |
---|---|---|---|---|
Al-Saran et al. | 3/23 | 0/23 | 7.00 (0.38–128.33) | 3 minor bleedings with LMWH, controlled with dose adjustment |
Bambauer et al. | 3/27 | 6/27 | 0.50 (0.14–1.80) | No indication if minor or major bleeding events |
Bramham et al. | 0/110 | 4/110 | 0.11 (0.01–2.04) | 4 minor bleeding episodes with UFH |
Lord et al. | 3/32 | 8/32 | 0.38 (0.11–1.29) | LMWH: 1 major and 2 minor bleedings; UFH: 8 minor bleedings |
Nurmohamed et al. | 3/35 | 0/35 | 7.00 (0.37–130.69) | 3 minor bleeding events with LMWH |
Saltissi et al.a | 12/36 | 6/36 | 2.00 (0.84–4.75) | LMWH:1 major and 11 minor bleedings; UFH: 6 minor bleedings |
Stefoni et al. | 0/54 | 7/54 | 0.07 (0.00–1.14) | 7 minor bleeding events with UFH |
Schrader et al.b | 0/35 | 0/35 | excluded | n/a |
Yang et al. (part 1)b | 0/10 | 0/10 | excluded | n/a |
Summary | 24/362 | 31/362 | 0.76 (0.26–2.22) |